首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   88505篇
  免费   6713篇
  国内免费   265篇
耳鼻咽喉   1069篇
儿科学   2406篇
妇产科学   1453篇
基础医学   12033篇
口腔科学   1292篇
临床医学   9336篇
内科学   18517篇
皮肤病学   1153篇
神经病学   8610篇
特种医学   3357篇
外科学   14214篇
综合类   1028篇
一般理论   94篇
预防医学   6699篇
眼科学   2172篇
药学   5888篇
中国医学   107篇
肿瘤学   6055篇
  2023年   696篇
  2022年   1091篇
  2021年   2546篇
  2020年   1431篇
  2019年   2336篇
  2018年   2675篇
  2017年   1901篇
  2016年   2024篇
  2015年   2343篇
  2014年   3402篇
  2013年   4317篇
  2012年   6850篇
  2011年   7162篇
  2010年   3910篇
  2009年   3465篇
  2008年   5730篇
  2007年   5984篇
  2006年   5597篇
  2005年   5498篇
  2004年   4986篇
  2003年   4524篇
  2002年   4130篇
  2001年   899篇
  2000年   680篇
  1999年   821篇
  1998年   881篇
  1997年   678篇
  1996年   556篇
  1995年   515篇
  1994年   476篇
  1993年   478篇
  1992年   458篇
  1991年   371篇
  1990年   394篇
  1989年   365篇
  1988年   362篇
  1987年   321篇
  1986年   310篇
  1985年   311篇
  1984年   319篇
  1983年   268篇
  1982年   309篇
  1981年   305篇
  1980年   221篇
  1979年   211篇
  1978年   203篇
  1977年   178篇
  1976年   136篇
  1975年   147篇
  1974年   138篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal...  相似文献   
4.
5.
Abstract

Objective

Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies.  相似文献   
6.
7.
8.
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patterns in these patients.Methods Clinicopathological factors were analysed using multivariable Cox regression assessing time to death and recurrence. Computed tomography-estimated tumour volume change was examined in a subgroup of consecutive patients.Results Five hundred and fifty-five patients were included. Median survival was 55 months (Mandard 1–3) and 21 months (Mandard 4 and 5). In the Mandard 4 and 5 group (332 patients), comparison between complete nodal responders and persistent nodal disease showed improved survival (90 vs 18 months), recurrence rates (locoregional 14.75 vs 28.74%, systemic 24.59 vs 48.42%) and circumferential resection margin positivity (22.95 vs 68.11%). Complete nodal response independently predicted improved survival (hazard ratio 0.34 (0.16–0.74). Post-chemotherapy tumour volume reduction was greater in patients with a complete nodal response (−16.3 vs −7.7 cm3, p = 0.033) with no significant difference between Mandard groups.Conclusion Patients with a complete nodal response to chemotherapy have significantly improved outcomes despite a poor Mandard score. High Mandard score does not correspond with a non-response to chemotherapy in all cases and patients with nodal downstaging may still benefit from adjuvant chemotherapy.Subject terms: Oesophageal cancer, Surgical oncology  相似文献   
9.
Arthroscopic acromioclavicular joint excision is a commonly performed but technically demanding procedure. Incomplete excision can leave residual symptoms. We present a simple, reproducible technique ensuring satisfactory excision of the joint.  相似文献   
10.
Coronavirus disease 2019 (COVID-19) has resulted in many challenges in patient care, especially among high-risk populations such as heart transplant recipients. Patients with heart transplant experience a significantly higher mortality rate with COVID-19 infection, and management is based on extrapolation from clinical trials done on nontransplant patients and from clinical experience. Here we report 4 cases of patients with heart transplant who presented with COVID-19 infection in late 2020. Patients presented with symptoms similar to those seen in the general population. All 4 patients were admitted to the hospital, and they were all treated with dexamethasone. In addition, 2 patients received remdesivir. Immunosuppressive medications were adjusted to maintain adequate levels of immunosuppression but at the same time allow for an adequate immune response against the infection. All patients were discharged alive from the hospital. We then performed a literature review on studies that included heart transplant patients who developed the infection and developed suggestions for a standardized management approach, which we share in this article.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号